Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study

Moussaoui, Sohela; Combes, Simon Jean-Baptiste; Ibáñez, Gladys; Gautier, Arnaud; Relyea, Bridget; Vignier, Nicolas

doi:10.1016/j.vaccine.2022.05.041

Cited by 6 publications

(5 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We used the three items derived from the WHO definition of VH (having ever refused, delayed or accepted a vaccine despite doubts) to construct a “General VH gradient” variable according to a previously published methodology. 28 , 29 This variable had four exclusive categories (in descending order of VH intensity): had ever refused a vaccine (“refusers”), had delayed but not refused a vaccine (“delayers”), had been vaccinated despite doubts, but never refused or delayed (“unsure acceptors”), or had never refused, delayed or accepted a vaccine with doubts (“no VH”).…”

Section: Methodsmentioning

confidence: 99%

Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022

Brosset,

Fressard,

Cogordan

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

In developed countries, vaccinations against hepatitis B (HBV), hepatitis A (HAV), and human papillomavirus (HPV) are often recommended to men who have sex with men (MSM) because of the risky sexual practices in which some engage. Vaccine coverage against these diseases is not optimal in France, probably due in part to vaccine hesitancy (VH). The overall aim of this survey among MSM was to estimate the prevalence of different grades of VH for these vaccines as well as of general VH (toward any vaccine). The specific objectives were to study the sociodemographic correlates of MSM specific and general VH and its association with vaccine uptake. A cross-sectional electronic survey (February–August 2022) collected information from 3,730 French MSM about their perceptions of HBV, HAV, and HPV and their related vaccines, to construct “specific VH” variables. Information about their past vaccination behaviors for any vaccine was used to construct a “general VH” variable, based on the World Health Organization definition. Almost 90% of MSM showed moderate or high specific VH for HBV, HAV, and/or HPV, and 54% general VH. A higher education level and comfortable financial situation were associated with lower grades of specific and general VH. Younger age was associated with less frequent specific VH and more frequent general VH. Specific VH, versus general, was more strongly associated with frequent self-reported non-vaccination against these three disease. Addressing their concerns about vaccines, improving their knowledge of vaccine-preventable sexually transmitted infections, and motivating them to get vaccinated are public health priorities.

show abstract

Section: Methodsmentioning

confidence: 99%

Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022

Brosset,

Fressard,

Cogordan

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…18 Another study carried out in France also showed that the longer Black immigrants had lived in France, the more hesitant they were about vaccination. 39 In addition to sociodemographic factors, the results showed that everyday racial discrimination and major racial discrimination were positively associated with mistrust of COVID-19 vaccines, while health literacy was negatively associated. Regarding COVID-19 vaccines, unfortunately, we found only one Canadian study that explored these factors with Black people.…”

Section: Results Concerning Age Did Not Confirm What Has Been Observedmentioning

confidence: 95%

“…A recent study among Black people showed that those who were born in Canada had higher score of VM 18 . Another study carried out in France also showed that the longer Black immigrants had lived in France, the more hesitant they were about vaccination 39 …”

Section: Discussionmentioning

confidence: 97%

COVID‐19 vaccine mistrust, health literacy, conspiracy theories, and racial discrimination among a representative ethnically diverse sample in Canada: The vulnerability of Arab, Asian, Black, and Indigenous peoples

Cénat,

Moshirian Farahi,

Dalexis

et al. 2024

Journal of Medical Virology

View full text Add to dashboard Cite

Despite increased risk of severe acute respiratory syndrome coronavirus 2 infections and higher rates of COVID‐19‐related complications, racialized and Indigenous communities in Canada have lower immunization uptake compared to White individuals. However, there is woeful lack of data on predictors of COVID‐19 vaccine mistrust (VM) that accounts for diverse social and cultural contexts within specific racialized and Indigenous communities. Therefore, we sought to characterize COVID‐19 VM among Arab, Asian, Black, and Indigenous communities in Canada. An online survey was administered to a nationally representative, ethnically diverse panel of participants in October 2023. Arabic, Asian, Indigenous, and Black respondents were enriched in the sampling panel. Data were collected on demographics, COVID‐19 VM, experience of racial discrimination, health literacy, and conspiracy beliefs. We used descriptive and regression analyses to determine the extent and predictors of COVID‐19 VM among racialized and Indigenous individuals. All racialized respondents had higher VM score compared to White participants. Among 4220 respondents, we observed highest VM among Black individuals (12.18; ±4.24), followed by Arabic (12.12; ±4.60), Indigenous (11.84; ±5.18), Asian (10.61; ±4.28), and White (9.58; ±5.00) participants. In the hierarchical linear regression analyses, Black participants, women, everyday racial discrimination, and major experience of discrimination were positively associated with COVID‐19 VM. Effects of racial discrimination were mediated by addition of conspiracy beliefs to the model. Racialized and Indigenous communities experience varying levels of COVID‐19 VM and carry specific predictors and mediators to development of VM. This underscores the intricate interaction between race, gender, discrimination, and VM that need to be considered in future vaccination campaigns.

show abstract

“…We used data collected from the 2021 French Health Barometer of Sante publique France. This national cross-sectional survey investigates health-seeking behaviours and perceptions, and has been regularly conducted by Santé publique France since 1992 [ 12 ]. The sampling method is based on random digit dialling of landline and cellular telephone numbers.…”

Section: Methodsmentioning

confidence: 99%

SARS-CoV-2 testing, infection and places of contamination in France, a national cross-sectional study, December 2021

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background This study aimed to describe the use of diagnostic testing for SARS-CoV-2 in France until December 2021, the characteristics of people infected, and places of contamination. Methods Data were collected from the national 2021 Health Barometer cross-sectional study, which was conducted between February and December 2021 and included French-speaking individuals aged 18–85 years old selected through randomly generated landline and mobile phone numbers. Participants were interviewed about COVID-19-like symptoms in the previous 12 months, diagnostic testing for SARS-CoV-2, positive diagnosis for SARS-CoV-2, and the place(s) of contamination. Determinants of diagnostic testing and of infection were studied using univariate and multivariate Poisson regressions. Results A total of 24,514 persons participated in the study. We estimated that 66.4% [65.0-67.7] of persons had been tested for SARS-CoV-2 the last time they experienced COVID-19-like symptoms, and that 9.8% [9.3–10.3] of the population in France - with or without symptoms - had been tested positive. Diagnostic testing was less frequent in men, unemployed persons, and people living alone; it was also less frequent during the first months of the pandemic. The estimated proportion of the population infected was higher in healthcare professionals (PRa: 1.5 [1.3–1.7]), those living in large cities ( > = 200 000 inhabitants, and Paris area) (1.4 [1.2–1.6]), and in households comprising > 3 persons (1.7 [1.5-2.0]). It was lower in retired persons (0.8 [0.6–0.97]) and those over 65 years old (0.6 [0.4–0.9]). Almost two-thirds (65.7%) of infected persons declared they knew where they were contaminated; 5.8% [4.5–7.4] reported being contaminated outdoors, 47.9% [44.8–51.0] in unventilated indoor environments, and 43.4% [40.3–46.6] in ventilated indoor environments. Specifically, 51.1% [48.0-54.2] declared they were contaminated at home or in a family of friend’s house, 29.1% [26.4–31.9] at their workplace, 13.9% [11.9–16.1] in a healthcare structure, and 9.0% [7.4–10.8] in a public eating place (e.g., cafeteria, bar, restaurant). Conclusions To limit viral spread, preventive actions should preferentially target persons tested least frequently and those at a higher risk of infection. They should also target contamination in households, healthcare structures, and public eating places. Importantly, contamination is most frequent in places where prevention measures are most difficult to implement.

show abstract

Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study

Cited by 6 publications

References 44 publications

Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022

Gradient of vaccine hesitancy among French men having sex with men: An electronic cross-sectional survey in 2022

COVID‐19 vaccine mistrust, health literacy, conspiracy theories, and racial discrimination among a representative ethnically diverse sample in Canada: The vulnerability of Arab, Asian, Black, and Indigenous peoples

SARS-CoV-2 testing, infection and places of contamination in France, a national cross-sectional study, December 2021

Contact Info

Product

Resources

About